Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

N. Fuente | Researchclopedia

Back to researchers

N. Fuente

Moffitt Cancer Center

45

Works

753

Citations

7

h-index

7

i10-index

Research Topics

Colorectal Cancer Treatments and Studies Lung Cancer Treatments and Mutations Cancer Treatment and Pharmacology

Affiliations

Merck (Germany)2020–2020

Pfizer (United Kingdom)2020–2020

Moffitt Cancer Center2024–2024

Institut de Virologie2020–2020

Stryker (United Kingdom)2020–2020

Top Works

Tumor lysis syndrome in a multiple myeloma treated with thalidomide

N. Fuente,J.M. Mañé,et al.

200432 citations

Gastric Cancer Management and Outcomes

Hepatocellular Carcinoma Treatment and Prognosis

Estrogen Receptor 1 Gene Expression and Its Combination with Estrogen Receptor 2 or Aromatase Expression Predicts Survival in Non-Small Cell Lung Cancer

Unai Aresti,Sergio Carrera,et al.

201423 citations

Biweekly Administration of Cisplatin/Gemcitabine in Advanced Nonsmall Cell Lung Cancer

Guillermo L pez-Vivanco,A. Viteri,et al.

200513 citations

Fixed-Dose-Rate Gemcitabine Infusion in Patients with Advanced Pancreatic or Biliary Tree Adenocarcinoma

Joan Manel Mañé,Aintzane Sancho,et al.

20107 citations

Factores pronósticos y predictivos en pacientes con cáncer de origen desconocido tratados con un esquema de quimioterapia con paclitaxel

Alberto Múñoz,N. Fuente,et al.

20047 citations

Gemcitabine (G) fixed-dose-rate infusion (FDR) plus erlotinib (E) in patients with advanced pancreatic cancer (APC).

Alberto Muñoz Llarena,J.M. Mañé,et al.

20116 citations

Gemcitabine and vascular toxicity

Alberto Múñoz,J.M. Mañé,et al.

20026 citations

Phase II Study of Docetaxel/Vinorelbine in Patients with non—small-Cell-Lung Cancer Previously Treated with Platinum-Based Chemotherapy

Alberto Múñoz,Itziar Rubio,et al.

20025 citations

Combination of oxaliplatin and capecitabine (CAPOX) in first and second-line treatment for metastatic colorectal carcinoma (MCRC)

Guillermo López-Vivanco,Alberto Múñoz,et al.

20044 citations